ZNG1B
gene geneOn this page
Summary
ZNG1B (Zn regulated GTPase metalloprotein activator 1B, HGNC:17907) is a protein-coding gene on chromosome 2q14.1, encoding Zinc-regulated GTPase metalloprotein activator 1B (Q8IUF1). Zinc chaperone that directly transfers zinc cofactor to target metalloproteins, thereby activating them. It is a selective cancer dependency (DepMap: 68.4% of cell lines).
Predicted to enable GTP binding activity; hydrolase activity; and metal ion binding activity. Predicted to be located in nucleus. Predicted to be active in cytoplasm.
Source: NCBI Gene 150472 — RefSeq curated summary.
At a glance
- GWAS associations: 4
- Clinical variants (ClinVar): 65 total
- Cancer dependency (DepMap): dependent in 68.4% of screened cell lines
- MANE Select transcript:
NM_172003
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:17907 |
| Approved symbol | ZNG1B |
| Name | Zn regulated GTPase metalloprotein activator 1B |
| Location | 2q14.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000136682 |
| Ensembl biotype | protein_coding |
| OMIM | 611079 |
| Entrez | 150472 |
Gene structure
Transcript identifiers
Ensembl transcripts: 30 — 22 protein_coding, 6 retained_intron, 2 nonsense_mediated_decay
ENST00000259199, ENST00000358604, ENST00000416503, ENST00000456188, ENST00000463627, ENST00000468417, ENST00000479583, ENST00000490323, ENST00000490446, ENST00000492566, ENST00000883248, ENST00000883249, ENST00000883250, ENST00000883251, ENST00000883252, ENST00000883253, ENST00000883254, ENST00000883255, ENST00000883256, ENST00000883257, ENST00000920858, ENST00000920859, ENST00000920860, ENST00000920861, ENST00000920862, ENST00000920863, ENST00000920864, ENST00000947888, ENST00000947889, ENST00000947890
RefSeq mRNA: 6 — MANE Select: NM_172003
NM_001330336, NM_001330337, NM_001330339, NM_001330340, NM_001330342, NM_172003
CCDS: CCDS2116, CCDS82502
Canonical transcript exons
ENST00000259199 — 15 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001819931 | 113437691 | 113438022 |
| ENSE00001890971 | 113495637 | 113496204 |
| ENSE00003465194 | 113471033 | 113471089 |
| ENSE00003466437 | 113460673 | 113460719 |
| ENSE00003468609 | 113462408 | 113462494 |
| ENSE00003469465 | 113482177 | 113482228 |
| ENSE00003478365 | 113454741 | 113454778 |
| ENSE00003503231 | 113441351 | 113441437 |
| ENSE00003505939 | 113495120 | 113495249 |
| ENSE00003510213 | 113493757 | 113493825 |
| ENSE00003565995 | 113444964 | 113445055 |
| ENSE00003587219 | 113443767 | 113443863 |
| ENSE00003629624 | 113453139 | 113453198 |
| ENSE00003679802 | 113465129 | 113465173 |
| ENSE00003692444 | 113493929 | 113493994 |
Expression profiles
Bgee: expression breadth ubiquitous, 134 present calls, max score 95.85.
Top tissues by expression
134 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| monocyte | CL:0000576 | 95.85 | gold quality |
| leukocyte | CL:0000738 | 95.39 | gold quality |
| islet of Langerhans | UBERON:0000006 | 94.66 | gold quality |
| adenohypophysis | UBERON:0002196 | 93.71 | gold quality |
| pancreas | UBERON:0001264 | 93.39 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 93.20 | gold quality |
| body of pancreas | UBERON:0001150 | 93.17 | gold quality |
| pituitary gland | UBERON:0000007 | 93.14 | gold quality |
| right adrenal gland | UBERON:0001233 | 93.09 | gold quality |
| left adrenal gland | UBERON:0001234 | 93.06 | gold quality |
| adrenal tissue | UBERON:0018303 | 93.06 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 92.87 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 92.75 | gold quality |
| gastrocnemius | UBERON:0001388 | 92.72 | gold quality |
| adrenal gland | UBERON:0002369 | 92.67 | gold quality |
| thyroid gland | UBERON:0002046 | 92.64 | gold quality |
| muscle of leg | UBERON:0001383 | 92.61 | gold quality |
| heart left ventricle | UBERON:0002084 | 92.35 | gold quality |
| nucleus accumbens | UBERON:0001882 | 92.24 | gold quality |
| lower esophagus | UBERON:0013473 | 92.20 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 92.20 | gold quality |
| endometrium | UBERON:0001295 | 92.18 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 92.08 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 92.03 | gold quality |
| heart | UBERON:0000948 | 91.96 | gold quality |
| right uterine tube | UBERON:0001302 | 91.95 | gold quality |
| calcaneal tendon | UBERON:0003701 | 91.74 | gold quality |
| tibial artery | UBERON:0007610 | 91.67 | gold quality |
| popliteal artery | UBERON:0002250 | 91.66 | gold quality |
| right atrium auricular region | UBERON:0006631 | 91.65 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
51 targeting ZNG1B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-MIR-3924 | 100.00 | 72.09 | 2394 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-548AB | 99.95 | 71.31 | 3488 |
| HSA-MIR-559 | 99.95 | 72.28 | 3609 |
| HSA-MIR-548A-5P | 99.94 | 71.27 | 3482 |
| HSA-MIR-548AD-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548AE-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548AK | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AM-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AP-5P | 99.94 | 71.14 | 3489 |
| HSA-MIR-548AQ-5P | 99.94 | 71.34 | 3426 |
| HSA-MIR-548AR-5P | 99.94 | 71.28 | 3515 |
| HSA-MIR-548AS-5P | 99.94 | 71.22 | 3482 |
| HSA-MIR-548AU-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AY-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548B-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548BB-5P | 99.94 | 71.27 | 3509 |
| HSA-MIR-548C-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548D-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548H-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548I | 99.94 | 71.25 | 3481 |
| HSA-MIR-548J-5P | 99.94 | 71.14 | 3489 |
| HSA-MIR-548O-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548W | 99.94 | 71.24 | 3488 |
| HSA-MIR-548Y | 99.94 | 71.28 | 3514 |
| HSA-MIR-101-3P | 99.94 | 75.03 | 2230 |
| HSA-MIR-380-3P | 99.89 | 70.18 | 1978 |
| HSA-MIR-221-3P | 99.86 | 71.56 | 1329 |
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 68.4% of screened cell lines.
Cross-species orthologs
0 orthologs
Paralogs (4): ZNG1E (ENSG00000147996), ZNG1A (ENSG00000172785), ZNG1C (ENSG00000196873), ZNG1F (ENSG00000215126)
Protein
Protein identifiers
Zinc-regulated GTPase metalloprotein activator 1B — Q8IUF1 (reviewed: Q8IUF1)
Alternative names: Cobalamin synthase W domain-containing protein 2
All UniProt accessions (4): C9J3G2, Q8IUF1, F8WEU0, F8WFD0
UniProt curated annotations — full annotation on UniProt →
Function. Zinc chaperone that directly transfers zinc cofactor to target metalloproteins, thereby activating them. Catalyzes zinc insertion into the active site of methionine aminopeptidase METAP1, which function to cleave the initiator methionine from polypeptides during or after protein translation. Mechanistically, the N-terminal psi-PxLVp motif binds to the C6H2-type zinc finger of inactive form of METAP1. After formation of the docked complex, zinc is transferred from the CXCC motif in the GTPase domain of ZNG1B to the zinc binding site in the peptidase domain of METAP1 in a process requiring GTP hydrolysis. GTP/GDP exchange is required for release of active METAP1.
Subcellular location. Nucleus.
Similarity. Belongs to the SIMIBI class G3E GTPase family. ZNG1 subfamily.
RefSeq proteins (6): NP_001317265, NP_001317266, NP_001317268, NP_001317269, NP_001317271, NP_742000* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR003495 | CobW/HypB/UreG_nucleotide-bd | Domain |
| IPR011629 | CobW-like_C | Domain |
| IPR027417 | P-loop_NTPase | Homologous_superfamily |
| IPR036627 | CobW-likC_sf | Homologous_superfamily |
| IPR051316 | Zinc-reg_GTPase_activator | Family |
Pfam: PF02492, PF07683
Catalyzed reactions (Rhea), 1 shown:
- GTP + H2O = GDP + phosphate + H(+) (RHEA:19669)
UniProt features (13 total): binding site 6, short sequence motif 2, chain 1, domain 1, sequence conflict 1, region of interest 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8IUF1-F1 | 75.45 | 0.36 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (6): 110; 203–206; 49–56; 107; 109; 110–114
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 71 (showing top):
GOBP_PROTEIN_MATURATION, chr2q14, GRADE_COLON_AND_RECTAL_CANCER_UP, GOMF_METALLOCHAPERONE_ACTIVITY, GOMF_MOLECULAR_CARRIER_ACTIVITY, MIR559, MIR548Y, MIR548BB_5P, MIR548AR_5P, MIR548AD_5P_MIR548AE_5P_MIR548AY_5P_MIR548B_5P_MIR548D_5P, MIR548AK_MIR548AM_5P_MIR548C_5P_MIR548H_5P_MIR548O_5P_MIR548AU_5P, MIR548O_5P_MIR548W, MIR548AB, MIR548AS_5P, MIR548A_5P
GO Biological Process (0):
GO Molecular Function (4): GTP binding (GO:0005525), hydrolase activity (GO:0016787), metal ion binding (GO:0046872), nucleotide binding (GO:0000166)
GO Cellular Component (2): nucleus (GO:0005634), cytoplasm (GO:0005737)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| guanyl ribonucleotide binding | 1 |
| purine ribonucleoside triphosphate binding | 1 |
| catalytic activity | 1 |
| cation binding | 1 |
| nucleoside phosphate binding | 1 |
| heterocyclic compound binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
286 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNG1B | CCDC74B | Q96LY2 | 542 |
| ZNG1B | SETD2 | Q9BYW2 | 497 |
| ZNG1B | TMEM14B | Q9NUH8 | 401 |
| ZNG1B | ZNF90 | Q03938 | 400 |
| ZNG1B | CHCHD5 | Q9BSY4 | 397 |
| ZNG1B | RABL2A | Q9UBK7 | 370 |
| ZNG1B | DHRS4 | Q9BTZ2 | 356 |
| ZNG1B | ARHGAP11B | Q3KRB8 | 347 |
| ZNG1B | FEM1C | Q96JP0 | 324 |
| ZNG1B | RCSD1 | Q6JBY9 | 323 |
| ZNG1B | ARHGAP42 | A6NI28 | 322 |
| ZNG1B | SLC35A1 | P78382 | 290 |
| ZNG1B | NOTCH2NLB | P0DPK3 | 288 |
| ZNG1B | STRN3 | Q13033 | 277 |
| ZNG1B | ZNF292 | O60281 | 274 |
IntAct
45 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CFTR | ESYT2 | psi-mi:“MI:0914”(association) | 0.710 |
| KLK5 | DENND11 | psi-mi:“MI:0914”(association) | 0.640 |
| ZNG1B | psi-mi:“MI:0915”(physical association) | 0.560 | |
| NSUN3 | HSPD1 | psi-mi:“MI:0914”(association) | 0.560 |
| ERF | TBL1X | psi-mi:“MI:0914”(association) | 0.530 |
| FAM174A | BLTP3B | psi-mi:“MI:0914”(association) | 0.530 |
| ADAMTS4 | MANBA | psi-mi:“MI:0914”(association) | 0.530 |
| ZNG1B | METAP1 | psi-mi:“MI:0914”(association) | 0.530 |
| OPALIN | BTAF1 | psi-mi:“MI:0914”(association) | 0.530 |
| ECE1 | ZNG1B | psi-mi:“MI:0915”(physical association) | 0.370 |
| CUL3 | PXDNL | psi-mi:“MI:0914”(association) | 0.350 |
| ZNG1B | TCERG1 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNG1A | AGAP1 | psi-mi:“MI:0914”(association) | 0.350 |
| SFTA2 | SEPTIN2 | psi-mi:“MI:0914”(association) | 0.350 |
| PAN2 | ARCN1 | psi-mi:“MI:0914”(association) | 0.350 |
| ELK1 | TPP1 | psi-mi:“MI:0914”(association) | 0.350 |
| ELK1 | PPP6C | psi-mi:“MI:0914”(association) | 0.350 |
| SMYD2 | HSPA4L | psi-mi:“MI:0914”(association) | 0.350 |
| M | psi-mi:“MI:0914”(association) | 0.350 | |
| ZNG1B | NME4 | psi-mi:“MI:0914”(association) | 0.350 |
| ZNG1A | TCERG1 | psi-mi:“MI:0914”(association) | 0.350 |
| HSPA12A | ARHGEF10 | psi-mi:“MI:0914”(association) | 0.350 |
| CBR4 | DUSP14 | psi-mi:“MI:0914”(association) | 0.350 |
| VEGFD | RPSA2 | psi-mi:“MI:0914”(association) | 0.350 |
| UCN3 | VWA8 | psi-mi:“MI:0914”(association) | 0.350 |
| DKKL1 | VWA8 | psi-mi:“MI:0914”(association) | 0.350 |
| GZMH | DENND11 | psi-mi:“MI:0914”(association) | 0.350 |
| ADAM7 | RIOK3 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (79): CBWD2 (Affinity Capture-MS), CBWD7 (Affinity Capture-MS), TUBB1 (Affinity Capture-MS), HSPA12A (Affinity Capture-MS), EGLN1 (Affinity Capture-MS), NEK4 (Affinity Capture-MS), METAP1 (Affinity Capture-MS), CBWD2 (Affinity Capture-MS), CBWD7 (Affinity Capture-MS), METAP1 (Affinity Capture-MS), TUBB1 (Affinity Capture-MS), CACHD1 (Affinity Capture-MS), TCERG1 (Affinity Capture-MS), HSPA12A (Affinity Capture-MS), CBWD2 (Affinity Capture-MS)
ESM2 similar proteins: A0A193KX02, A0A397HK53, A1Y9I9, A4IG53, A5WWC6, B6CZ46, B6CZ56, B6CZ62, B8NR70, L0TAD5, O42898, P37059, P55205, P58781, P86243, Q0IIS3, Q0P464, Q28C60, Q28DI5, Q2KHV5, Q2VQV9, Q32LS6, Q3V1F8, Q4V339, Q5JTY5, Q5RIA9, Q5XI69, Q5XI79, Q66KL0, Q68EZ3, Q6DCK1, Q6GQ37, Q6PE54, Q6Q2C2, Q6TL19, Q7L592, Q7L5L3, Q8IUF1, Q8IX18, Q8NKC1
Diamond homologs: B0R0B1, O74310, P24203, P31521, P33030, P53729, P94400, Q4V339, Q5JTY5, Q5RIA9, Q8IUF1, Q8VEH6, Q99MB4, Q9BRT8, P22042, P29937, Q869Q0, Q9HZQ2
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
65 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 49 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2552 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 2:113441345:TTATA:T | acceptor_loss | 1.0000 |
| 2:113441346:TATA:T | acceptor_loss | 1.0000 |
| 2:113441348:TA:T | acceptor_loss | 1.0000 |
| 2:113441350:G:GC | acceptor_loss | 1.0000 |
| 2:113441433:GGAAG:G | donor_gain | 1.0000 |
| 2:113441434:GAAG:G | donor_gain | 1.0000 |
| 2:113441434:GAAGG:G | donor_gain | 1.0000 |
| 2:113441435:AAGGT:A | donor_loss | 1.0000 |
| 2:113441436:AGG:A | donor_loss | 1.0000 |
| 2:113441438:G:C | donor_loss | 1.0000 |
| 2:113441438:G:GG | donor_gain | 1.0000 |
| 2:113441439:T:A | donor_loss | 1.0000 |
| 2:113443859:G:GG | donor_gain | 1.0000 |
| 2:113443861:G:GT | donor_gain | 1.0000 |
| 2:113443861:GAA:G | donor_gain | 1.0000 |
| 2:113443864:G:GG | donor_gain | 1.0000 |
| 2:113443869:G:GT | donor_gain | 1.0000 |
| 2:113443870:A:T | donor_gain | 1.0000 |
| 2:113444962:A:AG | acceptor_gain | 1.0000 |
| 2:113444963:G:GG | acceptor_gain | 1.0000 |
| 2:113445051:CCCAG:C | donor_loss | 1.0000 |
| 2:113445052:CCAG:C | donor_loss | 1.0000 |
| 2:113445053:CAG:C | donor_loss | 1.0000 |
| 2:113445054:AG:A | donor_loss | 1.0000 |
| 2:113445055:GG:G | donor_loss | 1.0000 |
| 2:113445057:T:A | donor_loss | 1.0000 |
| 2:113454735:TTGTA:T | acceptor_loss | 1.0000 |
| 2:113454736:TGTAG:T | acceptor_loss | 1.0000 |
| 2:113454737:GTAG:G | acceptor_loss | 1.0000 |
| 2:113454738:TAGG:T | acceptor_loss | 1.0000 |
AlphaMissense
2598 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 2:113462443:A:T | K204I | 0.998 |
| 2:113445023:T:A | I133K | 0.995 |
| 2:113437999:T:A | V44D | 0.992 |
| 2:113441356:G:T | G54W | 0.992 |
| 2:113441411:C:A | A72E | 0.992 |
| 2:113438013:G:T | G49W | 0.991 |
| 2:113441353:G:C | A53P | 0.991 |
| 2:113438014:G:A | G49E | 0.990 |
| 2:113441360:A:T | K55M | 0.990 |
| 2:113441363:C:T | T56I | 0.990 |
| 2:113462444:A:C | K204N | 0.990 |
| 2:113462444:A:T | K204N | 0.990 |
| 2:113441359:A:C | K55Q | 0.989 |
| 2:113441360:A:C | K55T | 0.989 |
| 2:113441361:G:C | K55N | 0.989 |
| 2:113441361:G:T | K55N | 0.989 |
| 2:113441417:T:C | I74T | 0.989 |
| 2:113441428:T:C | F78L | 0.989 |
| 2:113441430:T:A | F78L | 0.989 |
| 2:113441430:T:G | F78L | 0.989 |
| 2:113445023:T:G | I133R | 0.989 |
| 2:113445026:T:C | L134P | 0.989 |
| 2:113495160:T:A | V331D | 0.989 |
| 2:113445032:A:T | E136V | 0.988 |
| 2:113462443:A:C | K204T | 0.988 |
| 2:113441357:G:T | G54V | 0.987 |
| 2:113441357:G:A | G54E | 0.986 |
| 2:113443844:T:C | C107R | 0.986 |
| 2:113445013:T:C | F130L | 0.986 |
| 2:113445015:T:A | F130L | 0.986 |
dbSNP variants (sampled 300 via entrez): RS1000045085 (2:113476621 C>T), RS1000184934 (2:113440587 T>C), RS1000251478 (2:113487235 A>C), RS1000468439 (2:113441096 A>G), RS1000522571 (2:113439132 C>A,G), RS1000629982 (2:113447632 T>A,G), RS1000698428 (2:113449929 A>C,G,T), RS1000804990 (2:113439401 C>A), RS1000878191 (2:113469847 A>G), RS1001119675 (2:113455562 T>C), RS1001288340 (2:113466553 G>A,C), RS1001349992 (2:113456270 C>T), RS1001350255 (2:113469338 G>A,C), RS1001415890 (2:113447100 T>A,G), RS1001530990 (2:113484510 A>C,G)
Disease associations
OMIM: gene MIM:611079 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
4 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002711_1 | Sleep duration | 1.000000e-10 |
| GCST008841_1 | Depressive symptom (sleep problems) (binary trait) | 1.000000e-10 |
| GCST009391_645 | Metabolite levels | 9.000000e-06 |
| GCST012180_3 | Cigarettes smoked per day in Schizophrenia | 2.000000e-06 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007006 | depressive symptom measurement |
| EFO:0010504 | inositol measurement |
| EFO:0006525 | cigarettes per day measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
10 total (human), top 10 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | decreases expression | 1 |
| dicrotophos | decreases expression | 1 |
| testosterone undecanoate | affects cotreatment, decreases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| abrine | increases expression | 1 |
| jinfukang | decreases expression | 1 |
| Thiram | decreases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Levonorgestrel | affects cotreatment, decreases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.